Schweizerischer Nationalfonds / Fonds national suisse
Researchers working on an SNSF project have discovered novel, antibiotically active chemical substances in a previously rarely explored site: the leaf of a common field weed. The just published findings show that this microcosm contains many still unknown natural products that could lead to new drugs. Many of the antibiotics used today were developed from natural products made by ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - German Federal Institute for Drugs and Medical Devices (BfArM) recommends new formulation of Euthyrox® for approval in 21 EU countries - BfArM is acting as a representative of all 21 EU countries involved in the EU worksharing procedure Merck, a leading science and technology company, today ...
Bernardsville, New Jersey (ots/PRNewswire) - Anima Biotech today announced an agreement with Lilly for the discovery and development of translation inhibitors for several target proteins by using Anima's Translation Control Therapeutics platform. (Logo: https://mma.prnewswire.com/media/721538/Anima_Biotech_Logo.jpg ...
DGAP-News: BB BIOTECH AG / Key word(s): Half Year Results BB Biotech shares hold steady in the second quarter (news with additional features) 20.07.2018 / 07:00 The issuer is solely responsible for the content of this announcement. Media release as of July 20, 2018 Interim report of BB Biotech AG as of June 30, 2018 BB Biotech shares hold steady in the second quarter - Substantial portfolio adjustments, new investments ...
EQS Group-Ad-hoc: Polyphor AG / Key word(s): Miscellaneous Polyphor announces listing of new shares related to the convertible loan facility agreement with the Wellcome Trust 17-Jul-2018 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of ...
Hannover (ots) - Syntellix successfully passes a multi-stage admission and assessment process - Program offers selected German companies support in entering the US market and is supported by the German Federal Ministry for Economic Affairs and Energy - The United States, by far the largest market for implants worldwide, naturally offer enormous economic potential - ...
roelli roelli confectionery schweiz GmbH
Hannover (ots) - Important step for company´s North American strategy - Syntellix investor base now extends from Los Angeles to Singapore Syntellix AG, a fast-growing medical technology innovator that is in the process of disrupting the global orthopaedic implant market using patent-protected magnesium technology based on its innovations in material science and ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - Fertility.com is the gateway to two online portals: - Offering the latest scientific information to healthcare professionals in the advancing field of fertility - Supporting women, men and couples who are looking for information about fertility and/or undergoing fertility treatment (Photo: ...
Brussels (ots/PRNewswire) - - NEUPRO now approved in China for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's Disease as monotherapy (i.e. without levodopa) or in combination with levodopa - NEUPRO approval in China reinforces UCB's ongoing commitment to supporting patient value across China and to offering Chinese patients additional ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - QBOX IVF streamlines data transfer between lab instruments and Electronic Medical Record providers - Geri® Assess 2.0 enables automatic detection of key events in embryo and blastocyst development, improving efficiencies in assessment - Merck demonstrates commitment to further advance and ...
Astellas Pharma Europe Limited
Tokyo (ots/PRNewswire) - Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 percent compared to placebo plus androgen deprivation therapy[i] FOR EMEA MEDICAL MEDIA ONLY - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji ...
Schweizerischer Nationalfonds / Fonds national suisse
Doctors are increasingly fighting cancer by stimulating patients' immune systems. SNSF-supported researchers have now discovered a method for predicting the likelihood of treatment success. Immunotherapy changes a patient's immune system to allow it to attack cancer cells and either destroy them or at least keep them from growing. ...
JTI Japan Tobacco International AG
Geneva (ots/PRNewswire) - As the Annual Summit Takes Place This Week, Global Leaders Have an Opportunity to Scrutinize WHO's definition of transparency and accountability Health Ministers from 194 countries will gather this week in Geneva to set the direction for future health policy around the world. JTI - Japan Tobacco International - is calling for the Assembly to urgently address an alarming transparency and ...
JTI Japan Tobacco International AG
Geneva (ots/PRNewswire) - Analysis Disregards Pre-Existing Decline in Smoking Rates and Speculates that Objectives will be Met in the Long-Term The Australian Department of Health's Post-Implementation Review (PIR) of the Tobacco Plain Packaging Act[1], published today over eight months too late, comes to the shaky conclusion that the measure will work over time even ...
Milan (ots/PRNewswire) - The deal will speed up the commercialization of Xadago(R) for the treatment of Parkinson's Disease Nigaard is a pharmaceutical company well established in Denmark, Norway, Sweden, Iceland and Finland Zambon S.p.A., an international pharmaceutical company strongly committed to the Central Nervous System (CNS) therapeutic area and the Respiratory area with a focus on Rare Diseases, announced today ...